- ►chestpubs.org [PDF] TE Warkentin - Hematology/Oncology Clinics of North America, 2007 - Elsevier Heparin-induced thrombocytopenia (HIT) is an immune-mediated adverse drug effect
that is characterized by platelet activation, hypercoagulability, and a
resulting increased risk for thrombosis, both venous and arterial. This ... Cited by 905 - Related articles - BL Direct - All 40 versions
- ►chestpubs.org JI Weitz - Journal of thrombosis and thrombolysis, 2001 - Springer Abstract. Arterial and venous thrombosis are major causes of morbidity and
mortality. Arterial thrombosis is the most common cause of myocardial
infarction, stroke, and limb gangrene. Venous thrombosis leads to ... Cited by 250 - Related articles - BL Direct - All 24 versions
C Kearon, SR Kahn, G Agnelli, S Goldhaber, … - Chest, 2008 - Am Coll Chest Phys Page 1. DOI 10.1378/chest.08-0658 2008;133;454S-545S Chest Gary E. Raskob and
Anthony J. Comerota Clive Kearon, Susan R. Kahn, Giancarlo ... Cited by 211 - Related articles - All 16 versions
PA Kyrle, S Eichinger - The Lancet, 2005 - Elsevier Deep vein thrombosis and its sequelae pulmonary embolism and post-thrombotic
syndrome are some of the most common disorders. A thrombus either arises
spontaneously or is caused by clinical conditions including surgery, ... Cited by 168 - Related articles - All 14 versions
- ►hematologylibrary.org TE Warkentin, RJ Cook, VJ Marder, JAI … - Blood, 2005 - bloodjournal.hematologylibrary.org Heparin-induced thrombocytopenia (HIT) is caused by platelet-activating IgG
antibodies that recognize platelet factor 4 (PF4) bound to heparin.
Immunogenicity of heparins differs in that unfractionated heparin (UFH) ... Cited by 116 - Related articles - BL Direct - All 5 versions
- ►nejm.org VF Tapson - Cardiology clinics, 2004 - Elsevier Pulmonary embolism (PE) occurs when venous thrombosis, usually from the deep
veins of the proximal legs, travels to the lungs causing a potential spectrum of
consequences, including dyspnea, chest pain, hypoxemia, and sometimes ... Cited by 108 - Related articles - BL Direct - All 29 versions
- ►chestpubs.org TE Warkentin, A Greinacher, A Koster, AM … - Chest, 2008 - chestjournal.chestpubs.org This chapter about the recognition, treatment, and prevention of heparin-induced
thrombocytopenia (HIT) is part of the Antithrombotic and Thrombolytic Therapy:
American College of Chest Physicians Evidence-Based Clinical Practice ... Cited by 105 - Related articles - All 11 versions
- ►zhaoys.com [PDF] C Kearon, JS Ginsberg, JA Julian, J Douketis … - Jama, 2006 - Am Med Assoc You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do
to make your experience on this site better. Cited by 88 - Related articles - BL Direct - All 12 versions
JI Weitz, SM Bates - Journal of Thrombosis and Haemostasis, 2005 - interscience.wiley.com Summary. The limitations of heparin and warfarin have prompted the development
of new anticoagulant drugs for prevention and treatment of venous and arterial
thromboembolism. Novel parenteral agents include synthetic analogs of the ... Cited by 84 - Related articles - BL Direct - All 4 versions
S Schulman, RJ Beyth, C Kearon, MN Levine - Chest, 2008 - chestjournal.chestpubs.org This article about hemorrhagic complications of anticoagulant and thrombolytic
treatment is part of the Antithrombotic and Thrombolytic Therapy: American
College of Chest Physicians Evidence-Based Clinical Practice Guidelines ... Cited by 60 - Related articles - All 12 versions
